However, the receptors of adiponectin representing probable targets of therapy in obesity-oriented disorders have been demonstrated to be decreased in conditions of obesity and diabetes [20], and the mechanisms are largely unknown. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.